EndoSound Receives FDA Clearance for Revolutionary EUS Technology

EndoSound Inc. secures FDA clearance for its revolutionary EndoSound Vision System (EVS), a groundbreaking endoscopic ultrasound (EUS) technology. The system aims to enhance patient safety, reduce costs, and make critical medical care more accessible, potentially shifting care to ambulatory surgery centers. The company's CEO, Dr. Stephen Steinberg, expresses excitement about the milestone, emphasizing the company's dedication to advancing medical technology and improving patient outcomes.